YOLFTbeta
Paradigm Biopharmaceuticals Ltd

Paradigm Biopharmaceuticals Ltd

PAR · AU · Healthcare / Biotechnology

0.245AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.245
Open0.245
Day Range0.245 – 0.245
52-Week Range0.135 – 0.47
Volume0
Market Cap153.48M
P/E (TTM)0.00
Forward P/E8.12
EPS-0.15
Dividend Yield0.00%
Beta0.02
50-Day Avg0.2147
200-Day Avg0.2303

About

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Paul John Rennie BSc, Grad Dip, MBM, MSTC
  • Employees0
  • Headquarters500 Collins Street, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://www.paradigmbiopharma.com

Leadership

  • Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTCFounder, MD & Executive Chairman · b. 1959
  • Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.Company Secretary & CFO · b. 1982
  • Dr. Ravi KrishnanChief Scientific Officer
  • Mr. Simon WhiteDirector of Investor Relations
  • Dr. Michael ImperialeGlobal Head of Drug Safety & MPS
  • Dr. Donna L. Skerrett M.D., MSChief Medical Officer · b. 1957
  • Ms. Beverley HuttmannCommercial Head
  • Dr. Mukesh AhujaGlobal Clinical Head of OA

Financials

Income Statement

Currency: AUD2014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue07.33K1.29M1.82M2.68M2.98M4.70M20.55K79.22K46.76K65.80K52.12K80.15K
Growth (%)--+17507.00%+41.25%+47.17%+11.22%+57.36%-99.56%+285.52%-40.98%+40.72%-20.79%+53.78%
Cost of Revenue002.54K16.63K15.35K8.35K213.12K99.14K143.75K18.83K8.99K72.01K162.52K
Gross Profit001.29M1.81M2.67M2.98M-213.00K-78.59K-64.53K27.93K56.81K-19.89K-82.37K
Gross Margin-0.00%99.80%99.12%99.40%99.73%-4.54%-382.42%-81.45%59.74%86.34%-38.17%-102.76%
Operating Expense231.00K1.57M5.61M7.93M11.59M11.72M16.75M42.27M46.95M51.92M65.25M22.87M61.03M
Operating Income-231.00K-1.57M-4.32M-6.12M-8.93M-8.75M-16.96M-42.34M-47.01M-51.89M-65.19M-22.89M-61.11M
Operating Margin--21459.75%-334.65%-335.93%-332.72%-293.13%-361.20%-206053.53%-59339.34%-110978.61%-99077.51%-43910.60%-76246.47%
EBITDA-7.33K-4.32M-6.12M-8.93M-8.95M-15.70M-42.40M-46.82M-51.89M-64.54M-25.25M-60.96M
EBITDA Margin-100.01%-334.65%-335.93%-332.72%-300.00%-334.34%-206316.81%-59094.47%-110978.61%-98083.59%-48436.95%-76058.84%
Net Income-231.00K-1.56M-2.92M-4.28M-6.19M-15.63M-12.30M-34.30M-39.25M-51.91M-58.65M-18.77M-56.33M
Net Income Margin--21350.61%-226.56%-234.50%-230.71%-523.73%-261.93%-166895.38%-49543.07%-111013.71%-89138.30%-36014.48%-70282.28%
R&D157.71K157.71K2.87M4.23M6.59M7.90M12.79M33.52M39.01M52.68M58.33M17.74M53.92M
R&D as % of Total Revenue-2151.57%222.22%232.20%245.81%264.64%272.47%163099.76%49242.65%112658.68%88653.50%34039.18%67269.50%
Interest Expense00000034.17K37.72K28.63K16.42K14.37K7.08K2.46M
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%0.73%183.56%36.14%35.11%21.84%13.59%3070.35%

Balance Sheet

Currency: AUD2014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets216.80K15.04M12.35M14.35M15.19M85.51M112.36M84.79M50.69M67.07M27.39M24.57M30.55M
Total Liabilities368.67K577.33K1.12M955.29K1.33M2.70M4.18M6.52M8.38M13.39M3.58M3.39M27.08M
Total Equity-151.87K14.46M11.23M13.39M13.86M82.81M108.18M78.27M42.31M53.68M23.81M21.18M3.47M
Cash7.77K7.50M3.00M2.59M2.45M78.84M103.92M71.03M39.67M56.33M17.82M16.82M15.37M
Total Debt195.78K171.78K36.59K36.59K36.59K36.59K873.69K751.85K616.67K341.67K239.33K5.48K7.51M
Net Debt188.01K-7.33M-2.96M-2.55M-2.41M-78.80M-103.05M-70.28M-39.06M-55.99M-17.58M-16.81M-7.86M

Cash Flow

Currency: AUD2014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-617.72K-1.20M-3.59M-4.47M-6.01M-6.37M-10.09M-34.93M-32.21M-45.19M-65.94M-15.99M-43.69M
Investing Cash Flow-510.35K-237.98K-765.55K-1.92M-15.34K-6.52M5.62M668.37K00-46.20K-552.32K
Financing Cash Flow1.17M1.56M7.23M5.99M5.88M82.78M36.05M1.00M70.12K62.53M28.18M14.99M43.69M
Capital Expenditure12.97K237.98K12.97K19.95K3.05K17.78K130.89K31.63K4065.94M5491.12K
Free Cash Flow-617.72K-1.20M-3.60M-4.49M-6.02M-6.38M-10.22M-34.96M-32.21M-45.19M-65.94M-15.99M-43.69M
Dividends Paid--00--2.59M--58.87M---
FCF to OCF100.00%100.00%100.36%100.45%100.05%100.28%101.30%100.09%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF--0.00%0.00%---25.32%---130.29%---

Earnings

Report DateFeb 25, 2016Aug 31, 2016Feb 24, 2017Aug 29, 2017Feb 22, 2018Aug 24, 2018Feb 21, 2019Aug 29, 2019Feb 14, 2020Aug 27, 2020Feb 23, 2021Aug 26, 2021Feb 23, 2022Aug 25, 2022Feb 26, 2023Feb 27, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.000.00
EPS Actual-0.02-0.02-0.03-0.01-0.03-0.02-0.03-0.08-0.03-0.03-0.09-0.07-0.12-0.05-0.12-0.02-0.05
Surprise-----------------
Timing-----Pre-marketPre-marketAfter-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hours--

Key Statistics & Ratios

Market Cap153.48M
Enterprise Value145.54M
Trailing P/E0.00
Forward P/E8.12
Price / Sales1131.11
Price / Book44.22
EPS-0.15
Book Value0.006
Revenue (TTM)8.45K
Gross Profit (TTM)-12.13K
EBITDA-61.04M
Profit Margin0.00%
Operating Margin156513.05%
Return on Equity-456.96%
Return on Assets-138.75%
Shares Outstanding626.43M
Shares Float576.79M
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
4.63%
Insiders
9.42%
Retail / Other
85.95%

Top Fund Holders

  • Vanguard International Stock Index-Total Intl Stock Indx
    2.07M0.91%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    1.26M0.56%
  • Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
    545.80K0.24%
  • Schwab Strategic Tr-Schwab International Small Cap Equity ETF
    286.57K0.13%
  • Vanguard International Stock Index-Pacific Stock Index
    182.88K0.08%
  • SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
    96.29K0.04%
  • Allianz Fds Multi Strategy Tr-AllianzGI International Small Cap Fd
    91.48K0.04%
  • Vanguard Intl Equity Index - Total World Stock Index Fd
    65.62K0.03%
  • Allianz Fds-AllianzGI Global Small Cap Fd
    36.37K0.02%

Stock Splits

  • Nov 1, 20231097:1067
  • Aug 17, 2022415:412
  • Apr 17, 2019171:167